Abstract: Real Dysfunction Indicators in Lead
system, chromosomal aberration, decrease fertility, increase abortion, congenital malformation, abnormal DNA formation and renal dysfunction [1] [2] [3] [4] [5] [6] [7] . Lancereaux 8) reported that lead could cause renal disease. Aub et al. 9) and Oliver 10) showed that lead induced fibrosis of epithelial cells, atrophy and interstitial fibrosis in renal tubules. In animal experiments, Goyer et al. 11, 12) described intranuclear inclusion bodies induced by lead. Cramer et al. 13) reported the pathological findings of intranuclear inclusion bodies in lead exposed workers.
Kayson reported a risk of renal dysfunction at more than 60 µg/dl of blood lead (PbB), and more than 100 µg/dl of blood zinc protoporphyrin (ZPP) 14) . Researchers agree that there are difficulties in using blood urea nitrogen (BUN), serum-creatinine (S-creat) and urine protein as sensitive diagnostic indicators to detect renal dysfunction due to lead exposure. Several reports suggest that it is more appropriate to measure urine N-acetyl-β-D-glucosaminidase (U-NAG), urine albumin (Ualbumin), urine α 1 -microglobulin (U-α 1 -m), and urine β 2 -microglobulin (U-β 2 -m), which are accepted as sensitive indicators, to evaluate lead induced renal dysfunction [15] [16] [17] [18] [19] [20] [21] [22] . Early case detection depends on the identification of indicators which are sensitive to the earliest changes in renal function. In this study, we investigate which of a range of indicators are the most sensitive to such changes in renal function.
Subjects and Methods

Subjects
The study subjects were lead exposed workers undergoing regular health checks, once in six months by governmental regulation in Korea 23) . We randomly selected 27 male workers in the secondary lead smelter industry, 18 males in the plastic stabilizer industry and 30 males in the radiator manufacturing industry. Environmental lead concentrations in these work places were 0.0063 mg/m 3 , 0.0013 mg/m 3 and 0.0023 mg/m 3 , respectively. The subjects were divided into three groups only according to their blood lead level: highly exposed (PbB, above 60 µg/ dl), moderately exposed (PbB, 40 to 60 µg/dl) and slightly exposed group (PbB, under 40 µg/dl). As a control group, 64 male office workers who had not been occupationally exposed to lead were selected.
Measurements
We chose PbB, ZPP, urine lead (PbU), urine coproporphyrin (CPU), δ-aminolevulinic acid dehydratase activity (ALAD), and urine δ-aminolevulinic acid (ALAU) as lead exposure indicators. We collected blood and urine samples in the afternoon near the endshift. PbB and PbU were analyzed in an atomic absorption spectrophotometer (Shimadzu 670-G), ZPP in a hematofluorometer (AVIV 206, USA), ALAD by Tomokuni's new method 24) , ALAU by Tomokuni and Ogata's method 25) and CPU by Soulsby and Smith's simplified method 26) . BUN, S-creat., serum uric acid (S-UA), U-NAG, U-albumin, U-α 1 -m and U-β 2 -m were chosen to evaluate renal function. BUN was measured by the Urease-UV method, S-creat. by Jaffe's modified method and S-UA by the Uricase-OPD method 27) . U-NAG activity was measured after gel filtration of the urine samples with kits (Shionogi, Japan) 28) . U-albumin was measured in a turbidimeter (Boehring, Germany) 29) and U-α 1 -m and U-β 2 -m were analyzed by radioimmunoassay 19, 30) .
Statistical analysis
We calculated the arithmetic means of PbB, ZPP, PbU, BUN, S-creat. and S-UA. We found the geometric means of CPU, ALAD, ALAU, U-NAG, U-albumin, U-α 1 -m and U-β 2 -m by logarithmic transformation in order to achieve normal distribution. The t-test was used to compare the lead exposed and control group. ANOVA was used in the analysis of renal function changes with lead exposure. The Chi-squared test was used in the frequency analysis of subjects with renal function indicators above the normal range.
Results
Characteristics of subjects
The mean age of subjects was 40 to 44 years old, and there was no difference between exposed and control group. There was no difference among the four groups in the duration of employment (Table 1) .
Lead exposure indicators
Mean PbB levels in the highly exposed, moderately exposed, slightly exposed and control group were 74.6 ± 7.8 µg/dl, 46.5 ± 5.9 µg/dl, 24.3 ± 2.7 µg/dl and 7.9 ± 1.4 µg/dl, respectively. Mean ZPP levels in the highly and moderately exposed groups were significantly higher than in the control group. There was a significant difference between mean ALAD levels in the highly and moderately exposed groups and the control group. The mean ALAU level in each exposed group were significantly higher than in the control group (Table 2) .
PbB was highly correlated with ZPP, CPU, ALAD and ALAU. ZPP was highly correlated with PbU, CPU, ALAD and ALAU. PbU was correlated with only ALAD (Table 3 ). 
Renal function indicators
Mean BUN levels increased with increasing exposure levels of PbB, but statistical significance was found only between highly exposed and control group. Mean S-creat. and S-UA levels among groups did not show a trend. Mean U-NAG levels were slightly increased according to the levels of PbB, and mean U-albumin levels in the exposed groups were higher than in the control group, but statistical significance was not found. Mean U-α 1 -m levels increased with PbB levels from the slightly exposed and control group to the highly exposed group, and statistical significance was found between all exposed groups and the control group. Mean U-β 2 -m levels in the exposed groups were higher than in the control group, but statistical significance was not found (Table 4) . Table 5 shows the correlation coefficients between renal function indicators and lead exposure indicators in subjects. Significant correlations were found as follows; between BUN and PbB, ZPP, CPU, ALAD and ALAU; between S-creat. and CPU; between S-UA and CPU; between U-NAG and PbB, ZPP, CPU and ALAU; between U-α 1 -m and PbB, ZPP, CPU, ALAD and ALAU. 
83.9 ± 1.9 76.3 ± 1.9 63.8 ± 1.8 # : Geometric mean and standard deviation. *: p<0.05 (relationship between each exposed group and control). U-albumin and U-β 2 -m were not significantly correlated with any other lead exposure indicators. Table 6 shows the correlation coefficients among renal function indicators in subjects. The following significant correlations were found: between BUN and S-creat., S-UA and U-α 1 -m; between S-creat. and S-UA and U-α 1 -m; between U-NAG and U-α 1 -m; between U-albumin and U-α 1 -m and U-β 2 -m. U-α 1 -m was significantly correlated with all indicators except S-UA, but U-β 2 -m was significantly correlated with only U-albumin and U-α 1 -m.
The proportions of workers with high levels of BUN, S-creat., S-UA and U-albumin were not significantly related to lead exposure. For each exposed group, the proportions of workers with levels of U-NAG, U-α 1 -m and U-β 2 -m was significantly higher than in the control group (Table 7) .
Discussion
PbB, PbU, ALAD, ALAU, CPU and ZPP are commonly used as biological markers of lead exposure. The PbB level mainly reflects lead concentration in connective tissue, and does not closely correspond to the lead concentration in bone marrow, but PbB is more sensitive than other indicators to lead exposure levels. PbB is highly correlated to ZPP, PbU and ALAD, and is accepted as the most effective indicator among lead exposure indicators 31) . In this study, PbB, ZPP, CPU, ALAD and ALAU showed statistically significant differences between the exposed and control group, but PbU did not show a difference.
Our results showed that ALAU was more statistically significant than ALAD, which was different from the general concept. We therefore reanalyzed our samples, but could not find wrong procedure during analysis or any other problem.
Kim and Kim 32) , Kim et al. 33) and Lee et al. 34) reported that PbB significantly correlated with all other lead exposure indicators, and Lee et al. 34) showed that PbB had high correlation with all other indicators except CPU. The difference between studies in detailed findings might be explained by occupational characteristics of subjects or confounding factors.
Lead poisoning causes renal impairment through tubular dysfunction (shown by aminoaciduria, hypophosphatemia with hyperphosphaturia or glycosuria). Goyer and Wilson 35) reported the reversible reaction of the renal tubule in early renal impairment and intranuclear inclusion bodies were produced by the mechanism of separation of lead in the cell. Intranuclear inclusion bodies are prominent in the early stage of lead . In patients with early renal disease, it is difficult to determine whether lead is an etiologic factor. Similarly, where lead exposure has occurred, early renal dysfunction is difficult to detect.
We found that the mean BUN values were related to the level of exposure. The mean BUN level in the highly exposed group was significantly higher than in the control group.
Endo et al. 16) studied lead smelter workers. Mean BUN levels in highly exposed, slightly exposed and control group were 17.5 ± 4.3 mg/dl, 14.8 ± 2.9 mg/dl-15.5 ± 4.1 mg/dl and 12.4 ± 4.3 mg/dl, respectively. These were similar to our findings.
Significant correlation was found between BUN and PbB, ZPP, CPU, ALAD and ALAU. The highest correlation was observed between BUN and ZPP, confirming the results of other researchers 36, 37) . Hammond et al. 38) reported that correlations between BUN and PbB, PbU and ALAU were significant. Endo et al. 16) reported that BUN was correlated with PbB and ALAU in lead workers, but not correlated with other lead exposure indicators. We found that BUN was correlated with S-creat., S-UA and U-α 1 -m. Hernberg 39) reported that the increase in BUN induced by renal dysfunction in lead exposed workers was 2-3% at a PbB level of 120 µg/dl, 50% at 160 µg/dl and 90% at 180 µg/dl, but there was no clear dose-response relationship. He could not confirm adverse renal effects below 80 µg/dl of PbB. Marga et al. 40) reported that high BUN and S-creat. concentrations were not significantly related to the PbB concentration in a group of exposed workers with average PbB levels of 50 µg/dl. We found that 23.8% of workers with PbB levels over 60 µg/dl also had high BUN levels. The conflicting results of studies may be due to other factors such as individual susceptibility, racial origin and the pattern of lead exposure.
BUN shows a significant relationship with five lead exposure indicators (PbB, ZPP, CPU, ALAD and ALAU) and with three other renal function indicators (S-creat., S-UA and U-α 1 -m). This suggests that BUN is a valuable indicator of lead induced renal dysfunction.
Endo et al. 16) reported that there was no correlation between S-creat. and other lead exposure indicators in lead exposed workers. Omae et al. 41) reported that Screat., U-β 2 -m and uric acid were not significantly changed at a level of 36.5 µg/dl of PbB. These results were consistent with our findings.
Ahn et al. 42) reported the mean values for S-creat. in highly exposed, moderately exposed, slightly low exposed and control group. Their results were similar to ours. Regarding S-UA, we could find neither a significant difference between the lead exposed and control group, nor among the exposed groups, so that S-creat. and S-UA are not useful indicators of lead induced renal dysfunction. U-NAG activity is considered a sensitive indicator for estimating renal tubular dysfunction. Many reference ranges for U-NAG have been reported, but little agreement exists between them. Reference values must be agreed for consistent use of U-NAG in clinical practice.
Endo et al. 16) reported that the mean U-NAG values in highly and slightly exposed groups were 3.76 ± 2.30 U/g creat. and 2.59 ± 0.46-4.22 ± 1.76 U/g creat. Mean values reported elsewhere for U-NAG in highly and slightly exposed groups were 4.6 U/g creat. and 2.3-3.0 U/g creat. 17) In this study, the mean U-NAG values for highly, moderately and slightly exposed and control group were 3.7 ± 1.7 U/g creat., 2.9 ± 2.1 U/g creat., 2.2 ± 2.3 U/g creat. and 2.4 ± 2.2 U/g creat., respectively.
U-NAG shows a significant relationship with four lead exposure indicators (PbB, ZPP, CPU, ALAU). In contrast, U-NAG shows a significant relationship with only one other renal function indicator (U-α 1 -m). Endo et al. 16) reported U-NAG showed a significant relationship with PbB, ALAU and U-albumin, and that the proportions of each exposed group with a high U-NAG level was significantly different to the control group. U-NAG may therefore be considered a valuable indicator of lead induced renal dysfunction.
Verschoor et al. 15) studied the change in U-albumin according to the increase in the PbB concentration but they could not identify the precise mechanism. There are two possibilities in albuminuria in lead exposed workers. One is glomerular damage. The second possibility for the microalbuminuria is due to tubular dysfunction. Under normal conditions, small amounts of albumin pass through the glomerular basement membrane and are reabsorbed in proximal tubules, but albuminuria may appear in proximal tubular dysfunction 18) . We could not show any relationship between Ualbumin and lead exposure indicators. U-albumin did show a significant relationship with U-α 1 -m and U-β 2 -m. U-albumin is therefore not a helpful indicator of renal dysfunction. Increased U-α 1 -m appears prior to abnormal creatinine clearance in renal tubular dysfunction 20) . A significant increase in U-α 1 -m was observed in all exposed groups including those workers with less than 40 µg/dl of PbB. U-α 1 -m showed a highly significant relationship with all lead exposure indicators except PbU, and with all renal dysfunction indicators except S-UA. In addition, the proportions of each group with a high U-α 1 -m level showed a dramatic high trend with lead absorption. In our study, U-α 1 -m is clearly the earliest and the most useful indicator of renal dysfunction in lead exposed workers.
Mean U-β 2 -m did not show a relationship with the lead exposure level. Although Endo et al. 19) found a higher absolute level of U-β 2 -m in a lead exposed group than in our study, both studies recorded the highest U-β 2 -m levels in moderate lead exposure. U-β 2 -m did not show a significant relationship with lead exposure indicators in our study, and showed a significant relationship only with U-albumin and U-α 1 -m among renal dysfunction indicators. U-β 2 -m may be therefore not a suitable indicator of lead induced renal dysfunction.
We have studied a range of indicators of renal dysfunction in lead exposed workers. We have shown that BUN, U-NAG and U-α 1 -m are possible indicators, but U-α 1 -m is the most valuable, because U-α 1 -m levels vary with lead exposure and show highly significant correlations with lead exposure indicators. Similarly, U-α 1 -m is highly correlated with indicators of renal dysfunction except S-UA. In addition, the proportion of subjects with high U-α 1 -m levels shows a gradient with exposure. It has been suggested elsewhere that renal dysfunction occurs in lead exposed workers mainly at PbB levels of 60 µg/dl or greater 14) . Our findings support a lower threshold for the effect, and we argue that screening for renal dysfunction should be undertaken at PbB levels of 40 µg/dl or greater.
To sum up, BUN, U-NAG and U-α 1 -m were useful indicators of renal function, and U-α 1 -m was the most sensitive of the three. In the occupational field, this indicator would help in screening workers with renal problems.
Further research could be recommended in three areas. First, to refine the notional threshold level of PbB for renal dysfunction. Second, to confirm our findings in other studies. Third, in systematic reviews of original research work are needed in this important field.
